Depression Clinical Trial
Official title:
Non-Invasive Physiologic Sensors to Assess Depression
Verified date | February 2020 |
Source | Massachusetts General Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This project aims to use sensors to monitor physiological signals, sleep patterns, vocal characteristics, activity, location and phone usage in study patients with depression who are receiving standard treatment (compared with healthy controls).
Status | Completed |
Enrollment | 50 |
Est. completion date | January 3, 2020 |
Est. primary completion date | July 1, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: Patients with Depression (n=40): 1. Adults (ages 18-75), 2. Able to read, understand, and provide written informed consent in English, 3. Meet criteria for a primary psychiatric diagnosis of major depressive disorder for = 4 weeks, according to the M.I.N.I (Mini International Neuropsychiatric Interview), 4. Hamilton Depression Rating Scale (HDRS) total score = 18, 5. Engaged in or willing to be referred for clinical care for depression treatment as usual (antidepressants and/or psychotherapy), 6. Must have measurable skin conductance/electrodermal activity (as assessed at the screening visit), 7. Must own a working Android smartphone (Android 2.3+) and use it regularly, 8. Must own a windows PC (or tablet) or a Mac computer (or laptop), 9. Must have access to Internet service every day. Healthy Controls (n=10): 1. Adults (ages 18-75), 2. Able to read, understand, and provide written informed consent in English, 3. Not meet criteria for past or current psychiatric illness, excluding specific phobias, as measured by the M.I.N.I., 4. Not have a first-degree relative with known major psychiatric illness including Major Depressive Disorder, Bipolar Disorder, Psychotic Disorder or Substance Use Disorder, 5. Must have measurable skin conductance/electrodermal activity (as assessed at the screening visit), 6. Must own a working Android smartphone (Android 2.3+) and use it regularly, 7. Must own a windows PC (or tablet) or a Mac computer (or laptop), 8. Must have access to Internet service every day. Exclusion Criteria (for all subjects): 1. Active drug or alcohol use disorder in the past 3 months, 2. History of psychosis, 3. History of mania or hypomania, 4. Epilepsy or history of seizures, 5. Untreated hypothyroidism, 6. Unstable medical disease, 7. Cognitive impairment that would impede adherence to study procedures, 8. Acute suicide or homicide risk, 9. Current treatment with electroconvulsive therapy, vagal nerve stimulation therapy, deep brain stimulation, transcranial magnetic stimulation therapy, or phototherapy, 10. Concurrent participation in other research studies, 11. Cannot comprehend or communicate in English, 12. Lack of working smartphone or lack of daily access to Internet service, 13. Inability to measure skin conductance/electrodermal activity (as assessed at the screening visit), and 14. Inability or unwilling to, at minimum, wear the physiological sensor (E4) bands, fill out the surveys, and record a weekly diary. |
Country | Name | City | State |
---|---|---|---|
United States | Massachusetts General Hospital | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Massachusetts General Hospital |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Physiologic Biorhythms (heart rate) | We will measure the heart rate at baseline and during the treatment period. We will compare the corresponding patterns in patients with depression, as well as in healthy controls. | 8 weeks | |
Primary | Phone Usage | We will measure the cell-phone usage (in the form of texts, web browsing, and phone calls) at the beginning of the study and during the treatment period. We will compare the corresponding phone usage patterns in patients with depression, as well as in healthy controls. | 8 weeks | |
Primary | Voice Characteristics | We will measure the voice characteristics (via reading a 30-second script as part of an audio diary) at the beginning of the study and during the treatment period. We will compare the corresponding voice characteristics in patients with depression, as well as in healthy controls. | 8 weeks | |
Primary | Physiologic Biorhythms (Skin conductance) | We will measure the skin conductance at baseline and during the treatment period. We will compare the corresponding patterns in patients with depression, as well as in healthy controls. | 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A |